Blood Gas and Electrolyte Analyzer Market Report By Insights, Size, and Growth

The global market for blood gas and electrolyte analyzers is projected to decline from US$ 3.22 billion in 2023 to US$ 2.91 billion by 2031, reflecting a compound annual growth rate (CAGR) of 5.6% during the period from 2023 to 2031.

This report provides a forecast for the blood gas and electrolyte analyzer market, which can assist stakeholders in devising effective growth strategies. The increasing incidence of infectious diseases and the growing preference for rapid diagnostic solutions are significant factors propelling market expansion. Conversely, the lack of adequate reimbursement options poses a challenge to market growth. The rising number of patients in emergency departments and the growing adoption of point-of-care diagnostics are also contributing to market dynamics. However, the high costs associated with analyzers are expected to hinder market growth considerably throughout the forecast period.

Market Opportunities in the Blood Gas and Electrolyte Analyzer Sector

The advancement of the healthcare sector has led to a heightened demand for blood gas and electrolyte analyzers among healthcare providers globally. This surge in demand is fostering new product innovations, launches, and approvals on an international scale. Additionally, leading market players are engaging in research and development initiatives to promote the creation of more efficient products. Below are some notable recent product launches and advancements:

In July 2023, Siemens Healthineers introduced the Atellica CI Analyser, designed for clinical chemistry and immunoassay testing. The analyzer received FDA approval prior to its launch and is now available in various international markets.

In July 2022, during the 74th American Association for Clinical Chemistry Annual Scientific Meeting and Clinical Laboratory Exposition, EDAN Instruments, Inc. unveiled the i20, the first point-of-care fluorescence-based CO-OX blood gas and chemistry analysis system, which offers over 45 parameters, including blood gases, electrolytes, and CO-oximetry.

In April 2021, Siemens Healthineers launched the epoc Blood Analysis System, a portable, wireless device that delivers patient-side results in under a minute. It measures hematocrit and lactate using a single room temperature-stable test card, providing complete blood gas analysis and a basic metabolic panel. This system has been instrumental in supporting COVID-19 response efforts, as blood gas testing is crucial for managing affected patients.

The increase in product innovations, launches, and strategic partnerships among market participants is expected to create significant opportunities for the blood gas and electrolyte analyzer market in the years ahead.

Challenges Facing the Blood Gas and Electrolyte Analyzer Market

The considerable financial investments necessary for the acquisition, maintenance, and operation of blood gas and electrolyte analyzers can place a strain on the budgets of healthcare facilities, particularly smaller clinics, rural hospitals, and those in resource-limited areas. Various types of blood gas analyzers are available, including handheld, point-of-care, and traditional laboratory-based models. While traditional laboratory analyzers provide the most accurate results, they are also the slowest and most expensive. The costs of these instruments can range from US$ 25,000 to US$ 200,000 or more, depending on their features. Additionally, ongoing expenses for routine maintenance, calibration services, validation kits, consumables, electrodes, cartridges, and quality assurance must be factored into the total cost of ownership. These elevated costs can limit the accessibility of these essential diagnostic tools and affect healthcare providers' capacity to deliver comprehensive diagnostic services, especially in financially constrained environments.

By product type, the blood gas and electrolyte analyzer market is categorized into blood gas analyzers, electrolyte analyzers, combined analyzers, and others. The combined analyzer segment accounted for the largest market share in 2023.

In terms of end users, the market is segmented into hospitals and clinics, clinical and diagnostic laboratories, homecare settings, and others. The clinical and diagnostic laboratories segment held the largest market share in 2023.

Regional Insights on the Blood Gas and Electrolyte Analyzer Market

The United States is anticipated to be the leading market for blood gas and electrolyte analyzers, driven by factors such as the rising prevalence of cardiovascular and respiratory diseases, extensive clinical research, and contract research activities. Furthermore, the country is at the forefront of technological advancements, which have led to the development of various blood gas and electrolyte analyzers and their associated technologies. For example, in August 2023, Radiometer launched a new virtual learning platform called MyLearning, where patients can access e-learning modules, videos, quizzes, and augmented reality exercises related to Radiometer products and clinical applications.

Several key primary and secondary sources were consulted in the preparation of this report on the blood gas and electrolyte analyzer market, including data from the World Bank, the National Health Service (NHS), the US Department of Health and Human Services (HHS), and the World Health Organization (WHO).

Blood Gas and Electrolyte Analyzer Market Report By Insights, Size, and Growth - 2031

Market Opportunities in the Blood Gas and Electrolyte Analyzer Sector

Challenges Facing the Blood Gas and Electrolyte Analyzer Market

Regional Insights on the Blood Gas and Electrolyte Analyzer Market

TABLE OF CONTENTS

LIST OF TABLES

LIST OF FIGURES

Related Reports